nach oben

Reactions Weekly

Erschienen in:

01.08.2019 | Case report

Chloroquine/hydroxychloroquine

Bull's eye maculopathy and retinal damage: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 53-year-old woman developed retinal damage secondary to Bull's eye maculopathy during treatment with chloroquine and hydroxychloroquine [dosages and routes not stated] for lupus erythematosus. The findings of the adaptive optics scanning laser ophthalmoscopy confirmed the diagnosis of retinal damage associated with Bull's eye maculopathy [durations of treatments to reactions onsets and outcomes not stated]. …

Lee SE, et al. Evidence of retinal damage in chloroquine/hydroxychloroquine maculopathy as revealed by high resolution imaging: A case report utilizing adaptive optics scanning laser ophthalmoscopy. Investigative Ophthalmology and Visual Science 54: No. 15, Jun 2013. Available from: URL: https://iovs.arvojournals.org/article.aspx?articleid=2148227 [abstract] - USA

Titel: Chloroquine/hydroxychloroquine
Bull's eye maculopathy and retinal damage: case report
Publikationsdatum: 01.08.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-65858-6

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Chloroquine/hydroxychloroquine

Bull's eye maculopathy and retinal damage: case report

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Heparin

Bupropion/mirtazapine

Antineoplastics

Antituberculars/moxifloxacin/prednisone

Botulinum toxin A

Abatacept